Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-03-22
1992-10-27
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514317, 514319, 514331, 546197, 546205, 546206, 546229, 546236, 546237, 546238, 546239, A61K 31445, C07D21106, C07D21120, C07D40512
Patent
active
051589613
ABSTRACT:
Novel piperidine compounds having the formula ##STR1## wherein the symbols have the same meaning as set forth in the specification, and salts thereof with a pharmaceutically acceptable acid, are disclosed.
The novel compound are useful in the treatment of anoxia, migraine, ischemia and epilepsy.
REFERENCES:
patent: 3912743 (1975-10-01), Christensen
patent: 5019582 (1991-05-01), Drejer
Scarpelli et al. "Cell Injury" The Upjohn Co. Publisher, pp. 44-45 (1986).
Drejer Jorgen
Jakobsen Palle
Chang Celia
Hueschen Gordon W.
Ivy C. Warren
Novo Nordisk A S
LandOfFree
Piperidine compounds and their preparation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine compounds and their preparation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine compounds and their preparation and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-905748